Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Breo Ellipta® (fluticasone furoate/vilanterol) – Expanded indication and new strength
May 12, 2023 - The FDA approved GSK’s Breo Ellipta (fluticasone furoate/ vilanterol), for the maintenance treatment of asthma in patients aged 5 years and older.
